ABSTRACT: Experience of explantation of Trilucent breast implants
On 6 June 2000, the Medical Devices Agency (MDA) recommended that
all Trilucent (soya-bean-oil filled) breast implants should be
removed.This accelerated a trend that had already begun in our
This study follows our previous report on a 3 year series
of women with Trilucent breast implants. The aim was to present
our operative findings at explantation, and to correlate them
with the preoperative signs and symptoms, the postoperative complications
and the details of the hospital stay.
In total, 44 patients (82
implants) underwent explantation, of whom 34 were cosmetic cases
and 10 were reconstructive. Five patients had their implants
removed before the MDA announcement.
Implant rippling was the
most common problem reported (25%), followed by pain (18%), implant
deflation (9.1%) and capsular contracture (4.5%).
Free oil was
seen around the implant in 15 cases; four of these presented
with clinical deflation, and three with rippling. The remaining
eight patients were asymptomatic.
We conclude that these implants
tend to bleed, as evidenced by the presence of free oil around
the implant in 34% of patients. The absence of free oil in 73%
of the patients who presented with rippling suggests that the
leaking oil is often metabolised and absorbed.
The findings of
this study are significant for women in whom free oil was found
around the implant during explantation, and for those who still
have Trilucent implants in place, for whatever reason, in spite
of the MDA recommendation.
[05/13/2002; British Journal of Plastic Surgery]
Br J Plastic Surgery, 3/04
|Remember we are NOT Doctors and have NO medical training.|
This site is like an Encyclopedia - there are many pages, many links on many topics.
Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM.